During the past decade, Regional Hospital of Liepaja conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Hospital of Liepaja" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Tetherex Pharmaceuticals Corporation" with 1 trials sponsored and "Zuzana Zbožínková, M.Sc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Hospital of Liepaja" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Regional Hospital of Liepaja" are "Venous Thromboembolism" (2 trials), "Atrial Fibrillation" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Influenza" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Regional Hospital of Liepaja" in a lesser frequency.

Most popular intervention types in "Regional Hospital of Liepaja" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "Apixaban 2.5 mg" (1 trials) and "Apixaban placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Hospital of Liepaja" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Regional Hospital of Liepaja". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Regional Hospital of Liepaja, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Hospital of Liepaja, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".